Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

A candlelight vigil has been scheduled for 7:30 p.m. Sunday night outside the home to remember Sarah Rice. A candlelight vigil has been scheduled for 7:30 p.m. Sunday night outside the home to ...

Here is an updated list some of the major projects being planned in Bethlehem in ...